Dr Frank Plöger studied biology at Johannes Guntenberg University in Mainz and obtained his doctorate in Alzheimer’s research at Boehringer Ingelheim.
After his postdoc at the Center for Molecular Neurobiology Hamburg, Dr. Frank Plöger worked in various biotechnology and pharmaceutical companies, including Aventis, Biopharm GmbH, Sandoz/Hexal and Evonik AG.
He is a certified project manager and has been working in the fields of research & development, business development and patent management for more than 20 years.